General Pharmaceuticals Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 10-07-2024
- Paid Up Capital ₹ 1.12 M
as on 10-07-2024
- Company Age 64 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.41 M
as on 10-07-2024
- Revenue -5.05%
(FY 2022)
- Profit -416.10%
(FY 2022)
- Ebitda 12.76%
(FY 2022)
- Net Worth -3.71%
(FY 2022)
- Total Assets -3.71%
(FY 2022)
About General Pharmaceuticals
The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.12 M.
The company has closed loans amounting to ₹6.41 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aban Bhandari and Firoze Vakil serve as directors at the Company.
- CIN/LLPIN
U24239PN1960PTC132879
- Company No.
132879
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 1960
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does General Pharmaceuticals Private Limited offer?
General Pharmaceuticals Private Limited offers a wide range of products and services, including Hair Care, Hair Oils.
Who are the key members and board of directors at General Pharmaceuticals?
Executive Team (1)
FV
Firoze Vakil
Managing DirectorAppointment Date: 24-Sep-1982
Status: Current
Board Members(1)
Financial Performance and Corporate Structure Insights of General Pharmaceuticals.
General Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.05% decrease. The company also saw a substantial fall in profitability, with a 416.1% decrease in profit. The company's net worth dipped by a decrease of 3.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of General Pharmaceuticals?
In 2019, General Pharmaceuticals had a promoter holding of 92.26% and a public holding of 7.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Shamrao Vithal Co-Operative Bank Ltd. Creation Date: 29 Jan 2008 | ₹4.00 M | Satisfied |
The Shamrao Vithal Co-Op Bank Creation Date: 12 Feb 2002 | ₹0.30 M | Satisfied |
The Shamrao Vithal Co-Op Bank Creation Date: 15 May 1999 | ₹0.30 M | Satisfied |
How Many Employees Work at General Pharmaceuticals?
General Pharmaceuticals has a workforce of 5 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 22, 2010, General Pharmaceuticals has raised a total of ₹ 0.44 M, with the most recent deal valued at ₹ 0.44 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
